ConductScience.org, home

Paper41324820

CTC cluster in breast cancer: synergetic metastasis promotion mechanism and transformation path from platelet cloaking to leukocyte escort.

Guan C and 3 others. Clin Transl Oncol, 2026. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. CTC cluster in breast cancer: synergetic metastasis promotion mechanism and transformation path from platelet cloaking to leukocyte escort. Papers, record 41324820. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41324820

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CTC cluster in breast cancer: synergetic metastasis promotion mechanism and transformation path from platelet cloaking to leukocyte escort.
PubMed
Journal
Clin Transl Oncol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-11-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guan CCangtai
2Hao LLiangyu
3Gong BBiyao
4Zheng LLixianghttps://orcid.org/0009-0006-9463-6908

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Neoplastic Cells, CirculatingMajor topic
Blood PlateletsMajor topic
LeukocytesMajor topic
Humans
Female
Neoplasm Metastasis
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
20232ACB206053Natural Science Foundation of Jiangxi ProvincePubMed
20203BBCL73205Key Research and Development Program of Jiangxi ProvincePubMed

Source PubMed

Download CSV of grants

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140457073Phylogenetic inference reveals clonal heterogeneity in circulating tumor cell clusters.Nat Genet2025https://conductscience.org/library/papers/40457073PubMed
225367817Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: Effect on P-selectin, heparanase, metastasis and cellular recruitment.Glycobiology2015https://conductscience.org/library/papers/25367817PubMed
321512161Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target.Arterioscler Thromb Vasc Biol2011https://conductscience.org/library/papers/21512161PubMed
433473163Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial.Br J Cancer2021https://conductscience.org/library/papers/33473163PubMed
535455989Selectin-Mediated Signaling-Shedding Light on the Regulation of Integrin Activity in Neutrophils.Cells2022https://conductscience.org/library/papers/35455989PubMed
622591372Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.BMC Cancer2012https://conductscience.org/library/papers/22591372PubMed
734072844Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities.Cancers (Basel)2021https://conductscience.org/library/papers/34072844PubMed
831101536Partners in Crime: Neutrophil-CTC Collusion in Metastasis.Trends Immunol2019https://conductscience.org/library/papers/31101536PubMed
937770941The critical role of platelet in cancer progression and metastasis.Eur J Med Res2023https://conductscience.org/library/papers/37770941PubMed
1028956830Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target?Cancers (Basel)2017https://conductscience.org/library/papers/28956830PubMed
1129884204Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.Breast Cancer Res2018https://conductscience.org/library/papers/29884204PubMed
1225171411Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.Cell2014https://conductscience.org/library/papers/25171411PubMed
1324942131Living in shear: platelets protect cancer cells from shear induced damage.Clin Exp Metastasis2014https://conductscience.org/library/papers/24942131PubMed
1412029005Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system.Clin Chem2002https://conductscience.org/library/papers/12029005PubMed
1525984697A microfluidic device for label-free, physical capture of circulating tumor cell clusters.Nat Methods2015https://conductscience.org/library/papers/25984697PubMed
1631358544Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study.Clin Cancer Res2019https://conductscience.org/library/papers/31358544PubMed
1733391283Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease.Front Immunol2020https://conductscience.org/library/papers/33391283PubMed
1822014578Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs.Cancer Cell2011https://conductscience.org/library/papers/22014578PubMed
1922102277Engagement of αIIbβ3 (GPIIb/IIIa) with ανβ3 integrin mediates interaction of melanoma cells with platelets: a connection to hematogenous metastasis.J Biol Chem2012https://conductscience.org/library/papers/22102277PubMed
2035697674High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells.Nat Commun2022https://conductscience.org/library/papers/35697674PubMed

See all 72 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42771114A Meta-Analysis of Deep-Learning-Based Fusion of Positron Emission Tomography and Computed Tomography in Oncologic Imaging.J Imaging Inform Med2026https://conductscience.org/library/papers/42771114PubMed
42039449Loss of Mast cells and histaminergic signaling link diet to platelet-mediated NETosis and mammary cancer recurrence.bioRxiv2026https://conductscience.org/library/papers/42039449PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
SELP6403PubTator's text mininghttps://conductscience.org/library/genes/6403NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41324820

GET https://conductscience.org/api/papers/v1/41324820/references?page=2